rAAVen Partners with Prevail to Advance AAVs for Neurological Disorders

rAAVen Therapeutics is excited to announce a new partnership with Prevail Therapeutics to develop novel adeno-associated virus (AAV) capsids for disorders of the nervous system. (link)